1625P Multicenter, randomized, parallel group, phase II study to establish the efficacy and safety of CBP501, cisplatin, and nivolumab for ≥ third-line treatment of patients with exocrine pancreatic cancer and WBC
| Autor: | Enzler, T., Nguyen, A., Misleh, J., Cline, V.J., Johns, M.E., Shumway, N., Paulson, A.S., Siegel, R., Larson, T., Messersmith, W., Richards, D., Chaves, J., Pierce, E., Zalupski, M., Sahai, V., Orr, D., Kawabe, T., Ruste, S.A., Haun, A. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S900-S900 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|